Archive for: September 2008

Federal study finds that benign prostate disease can be relieved far better with mix of two usual drugs -- finasteride and doxazosin -- than with either separately

Jim Boeheim, who recently underwent prostate surgery, will resume coaching Syracuse basketball team in Dec 29 game against Buffalo

HealthDay - TUESDAY, Sept. 23 (HealthDay News) -- Older men with early-stage prostate cancer who are given hormone therapy before radiation seed implant therapy face a 20 percent greater risk of dying than those who get radiation treatment alone, new research suggests.

HealthDay - MONDAY, Sept. 22 (HealthDay News) -- A more intense but briefer course of radiation therapy is equally effective as the traditional longer course for certain breast cancer patients, Canadian researchers report.

HealthDay - THURSDAY, Sept. 18 (HealthDay News) -- Men receiving hormone-deprivation therapy for advanced but localized prostate cancer can develop bone loss as a side effect of the treatment.

Reuters - New research indicates that overweight patients with operable breast cancer are less likely than their normal-weight peers to achieve a complete response with chemotherapy.

HealthDay - WEDNESDAY, Sept. 10 (HealthDay News) -- Tumors often rebound rapidly following chemotherapy, and oncologists may now understand why: Blame the body.

Reuters - A new animal study suggests that antioxidant therapy may prevent the memory and attention problems that plague many cancer patients undergoing chemotherapy.

AP - Some 55 prostate cancer patients were given too-low doses of radiation treatment at the local Veterans Affairs hospital in the past 6 1/2 years, and federal investigators want to know why.

HealthDay - MONDAY, Sept. 8 (HealthDay News) -- Taking aspirin or other commonly used painkillers can lower blood levels of prostate-specific antigen (PSA) and possibly confuse the results of a common screening test for prostate cancer, a study finds.